H. Kristensen

Development and validation of a size exclusion chromatography method for determination of molecular masses and molecular mass distribution in low molecular weight heparin

H. Kristensen, E.M. Tromborg, Jørn Riis Nielsen et al. · Thrombosis Research · 1991 · 35 citations

Pharmacy, Biochemistry, Pharmaceutical Analysis +11

Effect of Tissue Factor Pathway Inhibitor (TFPI) in the HEPTEST® Assay and in an Amidolytic Anti Factor Xa Assay for LMW Heparin

H. Kristensen, Per Østergaard, Ole Nordfang et al. · Thrombosis and Haemostasis · 1992 · 21 citations

Medicine, Pharmacology, Hemostasis +15

The Significance of TFPI in Clotting Assays – Gomparison and Combination with other Anticoagulants

Ole Nordfang, H. Kristensen, Sanne Valentin et al. · Thrombosis and Haemostasis · 1993 · 19 citations

Medicine, Hematology, Pharmacology +17

Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model

Jan Holst, Annemarie T. Kristensen, H. Kristensen et al. · European Journal of Vascular and Endovascular Surgery · 1998 · 15 citations · Full text

Medicine, Hematology, Pharmacology +17

Simultaneous presence of tissue factor pathway inhibitor (TFPI) and low molecular weight heparin has a synergistic effect in different coagulation assays

S. Valentin, P. stergaard, H. Kristensen et al. · Blood Coagulation & Fibrinolysis · 1991 · 11 citations

Medicine, Biochemistry, Hematology +12